OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)

ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]

OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)

BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]

OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)

BioReference will offer COVID-19 testing for public drive-through facilities for Detroit residents ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Detroit residents by appointment. “The impact that expanded testing will […]

OPKO Health’s BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19)

ELMWOOD PARK, N.J., March 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the State of New Jersey to provide coronavirus disease 2019 (COVID-19) testing across the State. BioReference will provide testing for the first NJ drive-through facilities in Burlington, Essex, Hudson, Ocean and Union Counties. “Expanded testing […]

OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)

OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) BioReference Laboratories commits to testing 5,000 New Yorkers each day ELMWOOD PARK, N.J., March 17, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City […]

OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)

In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]

OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test

COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]

BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

Press Release Quote

ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]

Novitas Issues Final Local Coverage Determination for the 4Kscore® Test

Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019.  Full text of the […]

BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders

Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, […]